"Desmoglein 1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A desmosomal cadherin that is an autoantigen in the acquired skin disorder PEMPHIGUS FOLIACEUS.
| Descriptor ID |
D051183
|
| MeSH Number(s) |
D12.776.395.550.200.200.500.500.500 D12.776.543.550.200.200.500.500.500 D23.050.301.350.200.500.500.500 D23.050.422.124
|
| Concept/Terms |
Desmoglein 1- Desmoglein 1
- PFAN Protein
- Dsg1 Antigen
- Pemphigus Foliaceus Antigen
- Desmoglein I
- Desmosomal Glycoprotein 1
|
Below are MeSH descriptors whose meaning is more general than "Desmoglein 1".
Below are MeSH descriptors whose meaning is more specific than "Desmoglein 1".
This graph shows the total number of publications written about "Desmoglein 1" by people in this website by year, and whether "Desmoglein 1" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 2 | 3 |
| 2018 | 4 | 0 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Desmoglein 1" by people in Profiles.
-
Large International Validation of ABSIS and PDAI Pemphigus Severity Scores. J Invest Dermatol. 2019 01; 139(1):31-37.
-
Anti-desmoglein-1 levels as predictor of prednisolone tapering in pemphigus vulgaris patients treated with rituximab. Dermatol Ther. 2018 11; 31(6):e12671.
-
Epithelial barrier dysfunction in desmoglein-1 deficiency. J Allergy Clin Immunol. 2018 08; 142(2):702-706.e7.
-
Comparison of ethylenediaminetetraacetic acid-treated desmoglein ELISA and conventional desmoglein ELISA in the evaluation of pemphigus vulgaris in remission. J Am Acad Dermatol. 2018 Oct; 79(4):768-770.
-
Sixteen-year history of rituximab therapy for 1085 pemphigus vulgaris patients: A systematic review. Int Immunopharmacol. 2018 Jan; 54:131-138.
-
Quality of Life in Greek Patients with Autoimmune Bullous Diseases Assessed with ABQOL and TABQOL Indexes. Acta Derm Venereol. 2017 Oct 02; 97(9):1145-1147.
-
Anagen hair loss, anti-desmoglein 1, and pemphigus disease area index: a significant relationship? J Dtsch Dermatol Ges. 2017 Sep; 15(9):946-948.
-
Prospective studies on the routine use of a novel multivariant enzyme-linked immunosorbent assay for the diagnosis of autoimmune bullous diseases. J Am Acad Dermatol. 2017 May; 76(5):889-894.e5.